首页> 外文期刊>Journal of Ophthalmic Inflammation and Infection >Treatment of refractory uveitic macular edema with dexamethasone intravitreal implants in a pediatric patient with bilateral granulomatous idiopathic panuveitis: a case report
【24h】

Treatment of refractory uveitic macular edema with dexamethasone intravitreal implants in a pediatric patient with bilateral granulomatous idiopathic panuveitis: a case report

机译:地塞米松玻璃体植入物治疗小儿双侧肉芽肿性特发性胰腺炎难治性葡萄膜黄斑水肿1例

获取原文
           

摘要

Macular edema is a common complication of uveitis and represents a therapeutic challenge, especially in children. Recently, intravitreal dexamethasone implants have been shown to decrease intraocular inflammation and to control uveitic macular edema in patients with non-infectious intermediate or posterior uveitis. An 11-year-old boy with bilateral granulomatous idiopathic panuveitis and orbital inflammation experienced macular edema refractory to topical steroids and subcutaneous methotrexate. He was treated with off-label bilateral injections of dexamethasone intravitreal implant. Three months later, his vision had improved from 20/200 in both eyes to 20/30 in the right eye and 20/40 in the left eye. Optical coherence tomography showed complete resolution of the cystoid macular edema and subretinal fluid in both eyes. This is a rare report of the use of bilateral dexamethasone intravitreal implant in a pediatric patient. The implants achieved complete resolution of the uveitic macular edema with no adverse events 3 months post-implantation.
机译:黄斑水肿是葡萄膜炎的常见并发症,代表治疗挑战,尤其是对于儿童。最近,已经证明玻璃体内地塞米松植入物可以减少非感染性中间或后葡萄膜炎患者的眼内炎症并控制葡萄膜黄斑水肿。一个患有双侧肉芽肿性特发性胰腺炎和眼眶炎的11岁男孩经历了局部类固醇和皮下甲氨蝶呤难治的黄斑水肿。他接受了地塞米松玻璃体内植入物的标签外双侧注射治疗。三个月后,他的视力从双眼的20/200改善到右眼的20/30,左眼的改善了20/40。光学相干断层扫描显示两只眼睛的囊样黄斑水肿和视网膜下液完全消失。这是在儿童患者中使用双侧地塞米松玻璃体内植入物的罕见报道。植入物在植入后3个月内完全解决了葡萄膜黄斑水肿,无不良事件。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号